Form 4 for LONA LeonaBio, Inc.
Accepted 2021-07-21 00:00:00 ET · period of report 2021-07-21 · accession 0001209191-21-047601 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-07-21 | 2021-07-21 | LONA | MOEBIUS HANS | Chief Medical Off | M - OptEx | $1.35 | +28.4K | 30.4K | +1,381% | +$38.3K |
| D | 2021-07-21 | 2021-05-18 | LONA | MOEBIUS HANS | Chief Medical Off | A - Grant | $14.45 | +2,055 | 2,055 | New | +$29.7K |
| DM | 2021-07-21 | 2021-07-21 | LONA | MOEBIUS HANS | Chief Medical Off | M - OptEx | $0.00 | -28.4K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-07-21 | M | A | 12,610 | $1.35 | 14,665 | D | — | — | |
| 2 | Common | Common Stock | 2021-05-18 | A | A | 2,055 | $14.45 | 2,055 | D | — | — | (F1) The reporting person is voluntarily reporting the acquisition of shares of the issuer's common stock pursuant to the Athira Pharma, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the ESPP Purchase Period (as defined in the ESPP) of September 17, 2020 through May 18, 2021. This transaction is also exempt under Rule 16b-3(c). (F2) The Purchase Period ended May 18, 2021 and is the Purchase Period comprising the Offering Period (as defined in the ESPP) that began September 17, 2020. (F3) In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the initial public offering price from the issuer's initial public offering. |
| 3 | Common | Common Stock | 2021-07-21 | M | A | 15,762 | $1.35 | 30,427 | D | — | — | |
| 4 | Derivative | Stock Option (Right to Buy) | 2021-07-21 | M | D | 15,762 | $0.00 | 15,763 | D | $1.35 · — to 2029-08-14 | 15,762 Common Stock | (F5) One-fourth of the shares subject to the option vested on June 1, 2020 and one-fourth of the shares subject to the option vest on each year thereafter. |
| 5 | Derivative | Stock Option (Right to Buy) | 2021-07-21 | M | D | 12,610 | $0.00 | 0 | D | $1.35 · — to 2029-06-25 | 12,610 Common Stock | (F4) The shares subject to the option fully vested on April 1, 2021. |